SERA PROGNOSTICS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
SERA PROGNOSTICS, INC. (SERA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $4.25 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-08-12
- SERA PROGNOSTICS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2026-03-31 was $4.09, a 49.19% decline year-over-year.
- SERA PROGNOSTICS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2025-03-31 was $8.05, a 32.84% increase year-over-year.
- SERA PROGNOSTICS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2024-03-31 was $6.06, a 11.14% decline year-over-year.
- SERA PROGNOSTICS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2023-03-31 was $6.82, a 1.73% decline year-over-year.
- SERA PROGNOSTICS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2025 was $5.60, a 52.17% increase from fiscal 2024.
- SERA PROGNOSTICS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $3.68, a 13.41% decline from fiscal 2023.
- SERA PROGNOSTICS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $4.25, a 42.41% decline from fiscal 2022.
- SERA PROGNOSTICS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2022 was $7.38, a 55.37% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.25 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | $4.09 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | $5.60 10-K · filed 2026-03-18 | |||
| 2025-09-30 | $5.74 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $4.32 10-Q · filed 2025-08-06 | |||
| 2025-03-31 | $8.05 10-Q · filed 2025-05-07 | |||
| 2024-12-31 | $3.68 10-K · filed 2025-03-19 | |||
| 2024-09-30 | $3.98 10-Q · filed 2024-11-06 | |||
| 2024-06-30 | $3.62 10-Q · filed 2024-08-07 | |||
| 2024-03-31 | $6.06 10-Q · filed 2024-05-08 | |||
| 2023-12-31 | $4.25 10-K · filed 2024-03-20 | |||
| 2023-09-30 | $4.22 10-Q · filed 2023-11-08 | |||
| 2023-06-30 | $4.06 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | $6.82 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | $7.38 10-K · filed 2023-03-22 | |||
| 2022-09-30 | $7.52 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | $7.23 10-Q · filed 2022-08-10 | |||
| 2022-03-31 | $6.94 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | $4.75 10-K · filed 2022-03-29 | |||
| 2021-09-30 | $3.52 10-Q · filed 2021-11-09 | |||
| 2021-06-30 | $1.98 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |